Delivery Order SPE2DR25D6028-SPE2DR26FASNP
Award Date 12/9/25
Potential Completion Date 12/10/25
Potential Value $71K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $12,746.62 delivery order to AmerisourceBergen Drug Corp for Menveo vaccine (5-dose vials) on December 1, 2025, with completion targeted for December 2, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's substantial $999.99 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which runs...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Menveo vaccine (5-dose vials) with a ceiling value of $33,937.18. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Menveo vaccine (5-dose vial). This competitively awarded, non-set-aside delivery order has a ceiling value of $26,857.60 and firm fixed pricing. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran...
- The Defense Logistics Agency awarded a $13,071.76 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Menveo vaccine (5-dose vials). The contract is a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-competitive, non-set-aside delivery order issued under the company's existing contract vehicle with DLA. This delivery...
- The Defense Logistics Agency awarded a $53,326.80 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Menveo vaccine (5-dose vials) with an ultimate completion date of November 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $45,143 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Menveo 1 vial combination vaccine (A-C-Y-W-135) in 0.5ML format. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Menveo 1 vial (A-C-Y-W-135-DIP) 0.5mL vaccine, with a ceiling value of $6,449.00. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Menveo vaccine (5-dose vials) with a ceiling value of $10,748.79. This firm fixed-price delivery order, with a completion date of June 17, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $18,039.22 delivery order to AmerisourceBergen Drug Corp for Menveo vaccine (5-pack) on November 4, 2025, with completion expected by November 5, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger prime...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,290.30 on September 25, 2025, for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML vaccine product. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 26, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite...